The effect of cannabis on tremor in patients with multiple sclerosis

Neurology

Volumn 62, Issue 7, 2004, Pages 1105-1109

  Fox, Patrick ^a,d   Bain, P G ^b   Glickman, S ^c   Carroll, C ^a   Zajicek, J ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BUCKINGHAMSHIRE NEW UNIVERSITY   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; PLACEBO; TETRAHYDROCANNABINOL;

ACCELEROMETER; ADULT; ARTICLE; ATAXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TASK PERFORMANCE; TREMOR; VALIDATION PROCESS;

EID: 1842580669     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000118203.67138.3E     Document Type: Article

References (17)

1. Deuschl G, Bain PG, Brin M, Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord 1998;13:2-23.
2. Alusi SH, Worthington J, Glickman S, Bain PG. A study of tremor in multiple sclerosis. Brain 2001;124:720-730.
3. Weinshenker BG, Rice GP, Noseworthy JH, et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-1056.
4. Alusi SH, Glickman S, Aziz TZ, Bain PG. Tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;66:131-134.
5. Alusi SH, Aziz TZ, Glickman S, Jahanshahi M, Stein J, Bain PG. Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis. A prospective case-controlled study. Brain 2001;124:1576-1589.
6. Schurmann PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461-468.
7. Somerset M, Campbell R, Sharp DJ, Peters TJ. What do people with MS want and expect from healthcare services? Health Expect 2001;4: 29-37.
8. Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997;38:44-48.
9. Clifford DB. Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol 1983;13:669-671.
10. Meinck HM, Schonle PW, Conrad B. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 1989;236:120-122.
11. Baker D, Pryce G, Croxford JL, et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000;404:84-87.
12. Fox P, Thompson A, Zajicek J. A multicentre randomised controlled trial of cannabinoids in multiple sclerosis. J Neurol Sci 2001;187:S453. Abstract.
13. Alusi SH, Worthington J, Glickman S, Findley LJ, Bain PG. Evaluation of three different ways of assessing tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:756-760.
14. Mathowietz V, Weber K, Kashman N, Volland G. Adult norms for the nine-hole peg test of finger dexterity. Occup Ther J Res 1985;5:24-37.
15. Worthington J, De Souza LH. A simple measure of speed of index finger movement. Clin Rehab 1989;3:117-123.
16. Bain PG, Mally J, Gresty M, Findley LJ. Assessing the impact of essential tremor on upper limb function. J Neurol 1993;241:54-61.
17. Killestein J, Hoogervorst ELJ, Reif M, et al. Safety, tolerability and efficacy of orally administered cannabinoids in MS. Neurology 2002;58:1404-1407.